FILE:AMGN/AMGN-8K-20020813162316.txt.gz
EVENTS:	
TEXT:
ITEM: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ITEM 9.    REGULATION FD DISCLOSURE
 
On August 13, 2002, Amgen Inc. (the "Registrant") filed its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2002 (the "Form 10-Q") with the Securities and Exchange Commission. The Registrant's Form 10-Q was accompanied by the certifications required by 18 U.S.C.  1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, and the text of such certifications is set forth below:
 
 
Pursuant to 18 U.S.C.  1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Amgen Inc. (the "Company") hereby certifies that:
 
 
 
 
The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C.  1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference to any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing."
 
 
Pursuant to 18 U.S.C.  1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Amgen Inc. (the "Company") hereby certifies that:
 
 
 
 
The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C.  1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference to any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing."
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 


